Primus In News
Medtech MNCs bet big on localisation
04-05-2025
Vivek Tandon, Vice President, Primus Partners, emphasizes that India is no longer just a hub for low-cost manufacturing but a growing leader in global healthcare innovation. Highlighting the country’s cost advantages, skilled STEM talent, and supportive policies, he highlighted that medtech firms are increasingly embedding India into their core value chains. This shift is exemplified by Philips’ massive 650,000 sq ft campus, now its largest global innovation hub, which supports over 5,000 professionals and includes more than 36 labs. The facility also manufactures Affiniti Ultrasound machines under the ‘Make in India’ initiative.
Explore Related Insights
- Govt. announces Rs 1 lakh crore corpus for interest free loan to bolster research and innovation
- JioHotstar taps influencers to turn Wimbledon into a lifestyle experience for India’s young consumers
- Auto component makers fear US tariffs will hit their revenues
- Pharma stocks rise as US considers exempting generics from tariffs
